The tumor suppressor RASSF1A modulates inflammation and injury in the reperfused murine myocardium.

Inflammation is a central feature of cardiovascular disease, including myocardial infarction and heart failure. Reperfusion of the ischemic myocardium triggers a complex inflammatory response that can exacerbate injury and worsen heart function, as well as prevent myocardial rupture and mediate wound healing. Therefore, a more complete understanding of this process could contribute to interventions that properly balance inflammatory responses for improved outcomes. In this study, we leveraged several approaches, including global and regional ischemia/reperfusion (I/R), genetically modified mice, and primary cell culture, to investigate the cell type-specific function of the tumor suppressor Ras association domain family member 1 isoform A (RASSF1A) in cardiac inflammation. Our results revealed that genetic inhibition of RASSF1A in cardiomyocytes affords cardioprotection, whereas myeloid-specific deletion of RASSF1A exacerbates inflammation and injury caused by I/R in mice. Cell-based studies revealed that RASSF1A negatively regulates NF-κB and thereby attenuates inflammatory cytokine expression. These findings indicate that myeloid RASSF1A antagonizes I/R-induced myocardial inflammation and suggest that RASSF1A may be a promising target in immunomodulatory therapy for the management of acute heart injury. © 2019 Francisco et al.

Citation

Jamie Francisco, Jaemin Byun, Yu Zhang, Olivia Berman Kalloo, Wataru Mizushima, Shinichi Oka, Peiyong Zhai, Junichi Sadoshima, Dominic P Del Re. The tumor suppressor RASSF1A modulates inflammation and injury in the reperfused murine myocardium. The Journal of biological chemistry. 2019 Aug 30;294(35):13131-13144

Mesh Tags

Substances

PMID: 31311858

search → result